182 related articles for article (PubMed ID: 27649529)
1. HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.
Burian A; Wang KL; Finton KA; Lee N; Ishitani A; Strong RK; Geraghty DE
PLoS One; 2016; 11(9):e0163297. PubMed ID: 27649529
[TBL] [Abstract][Full Text] [Related]
2. HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1.
Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Zhang CX; Jackson E; Lisovsky I; da Fonseca S; Geraghty DE; Bernard NF
J Immunol; 2018 Jul; 201(1):113-123. PubMed ID: 29743316
[TBL] [Abstract][Full Text] [Related]
3. HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.
Goodridge JP; Burian A; Lee N; Geraghty DE
J Immunol; 2013 Oct; 191(7):3553-62. PubMed ID: 24018270
[TBL] [Abstract][Full Text] [Related]
4. A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors.
Klein K; Hölzemer A; Wang T; Kim TE; Dugan HL; Jost S; Altfeld M; Garcia-Beltran WF
Front Immunol; 2021; 12():798235. PubMed ID: 34917099
[TBL] [Abstract][Full Text] [Related]
5. Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1.
Garcia-Beltran WF; Hölzemer A; Martrus G; Chung AW; Pacheco Y; Simoneau CR; Rucevic M; Lamothe-Molina PA; Pertel T; Kim TE; Dugan H; Alter G; Dechanet-Merville J; Jost S; Carrington M; Altfeld M
Nat Immunol; 2016 Sep; 17(9):1067-74. PubMed ID: 27455421
[TBL] [Abstract][Full Text] [Related]
6. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
[TBL] [Abstract][Full Text] [Related]
7. The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides.
Hò GT; Hiemisch W; Pich A; Behrens GMN; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126487
[TBL] [Abstract][Full Text] [Related]
8. HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.
Kiani Z; Bruneau J; Geraghty DE; Bernard NF
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270222
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1.
Li H; Peng SL; Cui Y; Fu QX; Zhou Y; Wang QL; Zhan LS; Zhong S
Protein Pept Lett; 2010 May; 17(5):547-54. PubMed ID: 19995342
[TBL] [Abstract][Full Text] [Related]
10. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.
O'Connor GM; Vivian JP; Gostick E; Pymm P; Lafont BA; Price DA; Rossjohn J; Brooks AG; McVicar DW
J Virol; 2015 May; 89(10):5213-21. PubMed ID: 25740999
[TBL] [Abstract][Full Text] [Related]
11. Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.
O'Connor GM; Yamada E; Rampersaud A; Thomas R; Carrington M; McVicar DW
J Immunol; 2011 Sep; 187(5):2162-71. PubMed ID: 21804024
[TBL] [Abstract][Full Text] [Related]
12. Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.
Lunemann S; Schöbel A; Kah J; Fittje P; Hölzemer A; Langeneckert AE; Hess LU; Poch T; Martrus G; Garcia-Beltran WF; Körner C; Ziegler AE; Richert L; Oldhafer KJ; Schulze Zur Wiesch J; Schramm C; Dandri M; Herker E; Altfeld M
Gastroenterology; 2018 Nov; 155(5):1366-1371.e3. PubMed ID: 30031767
[TBL] [Abstract][Full Text] [Related]
13. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.
Gillespie GM; Bashirova A; Dong T; McVicar DW; Rowland-Jones SL; Carrington M
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):451-5. PubMed ID: 17411378
[TBL] [Abstract][Full Text] [Related]
14. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.
Dulberger CL; McMurtrey CP; Hölzemer A; Neu KE; Liu V; Steinbach AM; Garcia-Beltran WF; Sulak M; Jabri B; Lynch VJ; Altfeld M; Hildebrand WH; Adams EJ
Immunity; 2017 Jun; 46(6):1018-1029.e7. PubMed ID: 28636952
[TBL] [Abstract][Full Text] [Related]
16. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
[TBL] [Abstract][Full Text] [Related]
17. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
18. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
[TBL] [Abstract][Full Text] [Related]
20. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
